HomeIMUX • NASDAQ
add
Immunic Inc
Previous close
$1.37
Day range
$1.16 - $1.40
Year range
$0.51 - $1.51
Market cap
152.64M USD
Avg Volume
5.20M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 23.33M | -8.99% |
Net income | -19.30M | 23.34% |
Net profit margin | — | — |
Earnings per share | -0.07 | 72.00% |
EBITDA | -23.28M | 9.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.48M | -56.59% |
Total assets | 24.05M | -41.15% |
Total liabilities | 30.72M | 36.93% |
Total equity | -6.67M | — |
Shares outstanding | 130.46M | — |
Price to book | -22.75 | — |
Return on assets | -180.11% | — |
Return on capital | -2,245.14% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -19.30M | 23.34% |
Cash from operations | -19.28M | 16.03% |
Cash from investing | -11.00K | -266.67% |
Cash from financing | 59.00K | -23.38% |
Net change in cash | -19.65M | 16.04% |
Free cash flow | -15.75M | -7.29% |
About
CEO
Founded
May 2003
Website
Employees
92
